Affinity Asset Advisors, LLC

SEC CIK: 0001773195
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overview All 13F holders of NBIX Full Q2 2026 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2023

Holdings of NBIX by Affinity Asset Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−50,000−100.0%	Sold out	Holders
Q1 2025	50,000	$5.53M	0.9%	+50,000	New	Holders
Q1 2024	0	$0	0.0%	−10,000−100.0%	Sold out	Holders
Q4 2023	10,000	$1.32M	0.3%	+10,000	New	Holders